ArriVent Biopharma
AVBP16.7300.12% ( +0.020 )
已收盤: 10月9日 16:00:01 (美東)全部股東
股東類型
- 機構投資者66.80%
- 對沖基金17.28%
- 創投/私募13.43%
- 個人與內幕人士1.73%
- 私人企業0.76%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Montanova Capital, LLC | 9.16% | 451.55 萬 | 0.56% | +11.44 萬 | 30/06/2026 |
Infinitum Asset Management, LLC | 9.00% | 443.84 萬 | 0.16% | +28.95 萬 | 30/06/2026 |
Hillhouse Investment Management, Ltd. | 7.97% | 392.91 萬 | 0.70% | +0 | 30/06/2026 |
BlackRock, Inc. | 6.59% | 325.04 萬 | 1.01% | +72.01 萬 | 30/06/2026 |
OrbiMed Advisors LLC | 6.14% | 302.73 萬 | 0.54% | +0 | 30/06/2026 |
FMR LLC | 5.64% | 277.86 萬 | 1.02% | -23.72 萬 | 30/06/2026 |
HBM Healthcare Investments AG | 4.45% | 219.50 萬 | 0.39% | +0 | |
Eli Lilly Investment Consulting (Shanghai) Co., Ltd. | 4.15% | 204.61 萬 | 0.37% | +0 | 21/04/2025 |
Vanguard Capital Management, LLC | 4.13% | 203.42 萬 | 0.27% | +28.81 萬 | 30/06/2026 |
Octagon Capital Advisors LP | 4.00% | 197.11 萬 | 0.35% | +0 | 30/06/2026 |
Sofinnova Investments, Inc. | 3.44% | 169.68 萬 | 0.30% | +0 | 30/06/2026 |
State Street Investment Management | 3.43% | 169.30 萬 | 0.30% | +27.16 萬 | 30/06/2026 |
Vivo Capital, LLC | 3.41% | 168.21 萬 | 1.46% | +79.62 萬 | 30/06/2026 |
Novo Holdings A/S | 3.04% | 150.00 萬 | 1.24% | -44.21 萬 | 30/06/2026 |
General Catalyst Group Management, LLC | 3.03% | 149.48 萬 | 0.27% | +0 | 30/06/2026 |
Logos Global Management, L.P. | 2.03% | 100.00 萬 | 1.26% | +65.00 萬 | 30/06/2026 |
Geode Capital Management, LLC | 1.97% | 97.26 萬 | 0.20% | +16.90 萬 | 30/06/2026 |
D. E. Shaw & Co., L.P. | 1.77% | 87.20 萬 | 0.95% | +50.32 萬 | 30/06/2026 |
HongShan Capital Advisors Limited | 1.35% | 66.33 萬 | 0.12% | +0 | 30/06/2026 |
Point72 Asset Management, L.P. | 1.15% | 56.68 萬 | 0.50% | -18.14 萬 | 30/06/2026 |